nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Memantine—Alzheimer's disease	0.47	0.752	CbGbCtD
Famotidine—CYP2C19—Memantine—Alzheimer's disease	0.155	0.248	CbGbCtD
Famotidine—SLC22A8—choroid plexus—Alzheimer's disease	0.026	0.665	CbGeAlD
Famotidine—HRH2—nervous system—Alzheimer's disease	0.00182	0.0467	CbGeAlD
Famotidine—HRH2—central nervous system—Alzheimer's disease	0.00175	0.0449	CbGeAlD
Famotidine—SLC47A1—nervous system—Alzheimer's disease	0.00141	0.036	CbGeAlD
Famotidine—HRH2—brain—Alzheimer's disease	0.00139	0.0357	CbGeAlD
Famotidine—SLC47A1—central nervous system—Alzheimer's disease	0.00135	0.0347	CbGeAlD
Famotidine—SLC47A1—cerebellum—Alzheimer's disease	0.00132	0.0339	CbGeAlD
Famotidine—Hallucination—Galantamine—Alzheimer's disease	0.00116	0.00406	CcSEcCtD
Famotidine—Psychotic disorder—Memantine—Alzheimer's disease	0.00116	0.00405	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00115	0.00403	CcSEcCtD
Famotidine—Migraine—Rivastigmine—Alzheimer's disease	0.00114	0.00399	CcSEcCtD
Famotidine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00113	0.00396	CcSEcCtD
Famotidine—Irritability—Memantine—Alzheimer's disease	0.00113	0.00396	CcSEcCtD
Famotidine—Influenza—Donepezil—Alzheimer's disease	0.00113	0.00395	CcSEcCtD
Famotidine—Face oedema—Rivastigmine—Alzheimer's disease	0.00112	0.00392	CcSEcCtD
Famotidine—Tinnitus—Galantamine—Alzheimer's disease	0.00109	0.0038	CcSEcCtD
Famotidine—Dry skin—Memantine—Alzheimer's disease	0.00109	0.0038	CcSEcCtD
Famotidine—Bronchitis—Donepezil—Alzheimer's disease	0.00109	0.0038	CcSEcCtD
Famotidine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00108	0.00379	CcSEcCtD
Famotidine—Flushing—Galantamine—Alzheimer's disease	0.00108	0.00378	CcSEcCtD
Famotidine—SLC22A8—nervous system—Alzheimer's disease	0.00108	0.0276	CbGeAlD
Famotidine—SLC47A1—brain—Alzheimer's disease	0.00107	0.0275	CbGeAlD
Famotidine—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00107	0.00374	CcSEcCtD
Famotidine—Dry skin—Rivastigmine—Alzheimer's disease	0.00106	0.00372	CcSEcCtD
Famotidine—Dysuria—Donepezil—Alzheimer's disease	0.00106	0.00369	CcSEcCtD
Famotidine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00104	0.00365	CcSEcCtD
Famotidine—Pollakiuria—Donepezil—Alzheimer's disease	0.00104	0.00365	CcSEcCtD
Famotidine—Arrhythmia—Galantamine—Alzheimer's disease	0.00104	0.00364	CcSEcCtD
Famotidine—SLC22A8—central nervous system—Alzheimer's disease	0.00104	0.0266	CbGeAlD
Famotidine—Influenza—Memantine—Alzheimer's disease	0.00103	0.00359	CcSEcCtD
Famotidine—Mental disorder—Galantamine—Alzheimer's disease	0.00102	0.00357	CcSEcCtD
Famotidine—Bronchospasm—Memantine—Alzheimer's disease	0.00101	0.00353	CcSEcCtD
Famotidine—Depression—Donepezil—Alzheimer's disease	0.001	0.00351	CcSEcCtD
Famotidine—Dysgeusia—Galantamine—Alzheimer's disease	0.000994	0.00348	CcSEcCtD
Famotidine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000986	0.00345	CcSEcCtD
Famotidine—Bronchitis—Memantine—Alzheimer's disease	0.000986	0.00345	CcSEcCtD
Famotidine—Back pain—Galantamine—Alzheimer's disease	0.000982	0.00343	CcSEcCtD
Famotidine—Jaundice—Donepezil—Alzheimer's disease	0.000981	0.00343	CcSEcCtD
Famotidine—Muscle spasms—Galantamine—Alzheimer's disease	0.000976	0.00341	CcSEcCtD
Famotidine—Pancytopenia—Memantine—Alzheimer's disease	0.000974	0.0034	CcSEcCtD
Famotidine—Bronchitis—Rivastigmine—Alzheimer's disease	0.000964	0.00337	CcSEcCtD
Famotidine—Haematuria—Donepezil—Alzheimer's disease	0.00096	0.00336	CcSEcCtD
Famotidine—Dysuria—Memantine—Alzheimer's disease	0.000959	0.00335	CcSEcCtD
Famotidine—Neutropenia—Memantine—Alzheimer's disease	0.000959	0.00335	CcSEcCtD
Famotidine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000953	0.00333	CcSEcCtD
Famotidine—Pollakiuria—Memantine—Alzheimer's disease	0.000947	0.00331	CcSEcCtD
Famotidine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000944	0.0033	CcSEcCtD
Famotidine—Anaemia—Galantamine—Alzheimer's disease	0.000938	0.00328	CcSEcCtD
Famotidine—Dysuria—Rivastigmine—Alzheimer's disease	0.000938	0.00328	CcSEcCtD
Famotidine—Agitation—Galantamine—Alzheimer's disease	0.000933	0.00326	CcSEcCtD
Famotidine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000932	0.00326	CcSEcCtD
Famotidine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000926	0.00324	CcSEcCtD
Famotidine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000924	0.00323	CcSEcCtD
Famotidine—Bradycardia—Donepezil—Alzheimer's disease	0.00092	0.00322	CcSEcCtD
Famotidine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000915	0.0032	CcSEcCtD
Famotidine—Depression—Memantine—Alzheimer's disease	0.000911	0.00319	CcSEcCtD
Famotidine—Syncope—Galantamine—Alzheimer's disease	0.00091	0.00318	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000906	0.00317	CcSEcCtD
Famotidine—Hepatitis—Donepezil—Alzheimer's disease	0.000904	0.00316	CcSEcCtD
Famotidine—Hallucination—Donepezil—Alzheimer's disease	0.000899	0.00314	CcSEcCtD
Famotidine—Palpitations—Galantamine—Alzheimer's disease	0.000897	0.00314	CcSEcCtD
Famotidine—Pharyngitis—Donepezil—Alzheimer's disease	0.000897	0.00314	CcSEcCtD
Famotidine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000892	0.00312	CcSEcCtD
Famotidine—Depression—Rivastigmine—Alzheimer's disease	0.000892	0.00312	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000887	0.0031	CcSEcCtD
Famotidine—Cough—Galantamine—Alzheimer's disease	0.000886	0.0031	CcSEcCtD
Famotidine—Convulsion—Galantamine—Alzheimer's disease	0.00088	0.00308	CcSEcCtD
Famotidine—Haematuria—Memantine—Alzheimer's disease	0.000872	0.00305	CcSEcCtD
Famotidine—Myalgia—Galantamine—Alzheimer's disease	0.000864	0.00302	CcSEcCtD
Famotidine—Chest pain—Galantamine—Alzheimer's disease	0.000864	0.00302	CcSEcCtD
Famotidine—Arthralgia—Galantamine—Alzheimer's disease	0.000864	0.00302	CcSEcCtD
Famotidine—Anxiety—Galantamine—Alzheimer's disease	0.000861	0.00301	CcSEcCtD
Famotidine—Sinusitis—Memantine—Alzheimer's disease	0.000858	0.003	CcSEcCtD
Famotidine—Agranulocytosis—Memantine—Alzheimer's disease	0.000853	0.00298	CcSEcCtD
Famotidine—Haematuria—Rivastigmine—Alzheimer's disease	0.000853	0.00298	CcSEcCtD
Famotidine—Dry mouth—Galantamine—Alzheimer's disease	0.000845	0.00296	CcSEcCtD
Famotidine—Tinnitus—Donepezil—Alzheimer's disease	0.000843	0.00295	CcSEcCtD
Famotidine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000839	0.00293	CcSEcCtD
Famotidine—Confusional state—Galantamine—Alzheimer's disease	0.000835	0.00292	CcSEcCtD
Famotidine—Bradycardia—Memantine—Alzheimer's disease	0.000835	0.00292	CcSEcCtD
Famotidine—SLC22A8—brain—Alzheimer's disease	0.000824	0.0211	CbGeAlD
Famotidine—Hepatitis—Memantine—Alzheimer's disease	0.000821	0.00287	CcSEcCtD
Famotidine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000817	0.00286	CcSEcCtD
Famotidine—Hallucination—Memantine—Alzheimer's disease	0.000816	0.00286	CcSEcCtD
Famotidine—Shock—Galantamine—Alzheimer's disease	0.000815	0.00285	CcSEcCtD
Famotidine—Pharyngitis—Memantine—Alzheimer's disease	0.000814	0.00285	CcSEcCtD
Famotidine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000811	0.00284	CcSEcCtD
Famotidine—Arrhythmia—Donepezil—Alzheimer's disease	0.000807	0.00282	CcSEcCtD
Famotidine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000803	0.00281	CcSEcCtD
Famotidine—Hallucination—Rivastigmine—Alzheimer's disease	0.000799	0.00279	CcSEcCtD
Famotidine—Alopecia—Donepezil—Alzheimer's disease	0.000799	0.00279	CcSEcCtD
Famotidine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000797	0.00279	CcSEcCtD
Famotidine—Mental disorder—Donepezil—Alzheimer's disease	0.000792	0.00277	CcSEcCtD
Famotidine—Anorexia—Galantamine—Alzheimer's disease	0.00079	0.00276	CcSEcCtD
Famotidine—Erythema multiforme—Memantine—Alzheimer's disease	0.000776	0.00271	CcSEcCtD
Famotidine—Dysgeusia—Donepezil—Alzheimer's disease	0.00077	0.00269	CcSEcCtD
Famotidine—Tinnitus—Memantine—Alzheimer's disease	0.000765	0.00268	CcSEcCtD
Famotidine—Flushing—Memantine—Alzheimer's disease	0.000762	0.00266	CcSEcCtD
Famotidine—Back pain—Donepezil—Alzheimer's disease	0.000761	0.00266	CcSEcCtD
Famotidine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000759	0.00265	CcSEcCtD
Famotidine—Muscle spasms—Donepezil—Alzheimer's disease	0.000756	0.00265	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000755	0.00264	CcSEcCtD
Famotidine—Insomnia—Galantamine—Alzheimer's disease	0.000749	0.00262	CcSEcCtD
Famotidine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000748	0.00262	CcSEcCtD
Famotidine—Flushing—Rivastigmine—Alzheimer's disease	0.000745	0.00261	CcSEcCtD
Famotidine—Paraesthesia—Galantamine—Alzheimer's disease	0.000744	0.0026	CcSEcCtD
Famotidine—Somnolence—Galantamine—Alzheimer's disease	0.000737	0.00258	CcSEcCtD
Famotidine—Arrhythmia—Memantine—Alzheimer's disease	0.000733	0.00256	CcSEcCtD
Famotidine—Dyspepsia—Galantamine—Alzheimer's disease	0.000729	0.00255	CcSEcCtD
Famotidine—Anaemia—Donepezil—Alzheimer's disease	0.000727	0.00254	CcSEcCtD
Famotidine—Alopecia—Memantine—Alzheimer's disease	0.000725	0.00254	CcSEcCtD
Famotidine—Agitation—Donepezil—Alzheimer's disease	0.000723	0.00253	CcSEcCtD
Famotidine—Decreased appetite—Galantamine—Alzheimer's disease	0.00072	0.00252	CcSEcCtD
Famotidine—Mental disorder—Memantine—Alzheimer's disease	0.000719	0.00251	CcSEcCtD
Famotidine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000717	0.00251	CcSEcCtD
Famotidine—Fatigue—Galantamine—Alzheimer's disease	0.000714	0.0025	CcSEcCtD
Famotidine—Alopecia—Rivastigmine—Alzheimer's disease	0.000709	0.00248	CcSEcCtD
Famotidine—Constipation—Galantamine—Alzheimer's disease	0.000708	0.00248	CcSEcCtD
Famotidine—Syncope—Donepezil—Alzheimer's disease	0.000706	0.00247	CcSEcCtD
Famotidine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000703	0.00246	CcSEcCtD
Famotidine—Dysgeusia—Memantine—Alzheimer's disease	0.000699	0.00245	CcSEcCtD
Famotidine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000691	0.00242	CcSEcCtD
Famotidine—Back pain—Memantine—Alzheimer's disease	0.000691	0.00242	CcSEcCtD
Famotidine—Cough—Donepezil—Alzheimer's disease	0.000686	0.0024	CcSEcCtD
Famotidine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000684	0.00239	CcSEcCtD
Famotidine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000683	0.00239	CcSEcCtD
Famotidine—Convulsion—Donepezil—Alzheimer's disease	0.000682	0.00238	CcSEcCtD
Famotidine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000677	0.00237	CcSEcCtD
Famotidine—Back pain—Rivastigmine—Alzheimer's disease	0.000676	0.00236	CcSEcCtD
Famotidine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000672	0.00235	CcSEcCtD
Famotidine—Myalgia—Donepezil—Alzheimer's disease	0.00067	0.00234	CcSEcCtD
Famotidine—Arthralgia—Donepezil—Alzheimer's disease	0.00067	0.00234	CcSEcCtD
Famotidine—Chest pain—Donepezil—Alzheimer's disease	0.00067	0.00234	CcSEcCtD
Famotidine—Anxiety—Donepezil—Alzheimer's disease	0.000667	0.00233	CcSEcCtD
Famotidine—Anaemia—Memantine—Alzheimer's disease	0.00066	0.00231	CcSEcCtD
Famotidine—Agitation—Memantine—Alzheimer's disease	0.000656	0.0023	CcSEcCtD
Famotidine—Dry mouth—Donepezil—Alzheimer's disease	0.000655	0.00229	CcSEcCtD
Famotidine—Abdominal pain—Galantamine—Alzheimer's disease	0.000655	0.00229	CcSEcCtD
Famotidine—Body temperature increased—Galantamine—Alzheimer's disease	0.000655	0.00229	CcSEcCtD
Famotidine—Confusional state—Donepezil—Alzheimer's disease	0.000647	0.00226	CcSEcCtD
Famotidine—Anaemia—Rivastigmine—Alzheimer's disease	0.000646	0.00226	CcSEcCtD
Famotidine—Agitation—Rivastigmine—Alzheimer's disease	0.000642	0.00225	CcSEcCtD
Famotidine—Oedema—Donepezil—Alzheimer's disease	0.000642	0.00225	CcSEcCtD
Famotidine—Syncope—Memantine—Alzheimer's disease	0.000641	0.00224	CcSEcCtD
Famotidine—Leukopenia—Memantine—Alzheimer's disease	0.000639	0.00224	CcSEcCtD
Famotidine—Infection—Donepezil—Alzheimer's disease	0.000638	0.00223	CcSEcCtD
Famotidine—Shock—Donepezil—Alzheimer's disease	0.000632	0.00221	CcSEcCtD
Famotidine—Palpitations—Memantine—Alzheimer's disease	0.000631	0.00221	CcSEcCtD
Famotidine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000629	0.0022	CcSEcCtD
Famotidine—Loss of consciousness—Memantine—Alzheimer's disease	0.000628	0.0022	CcSEcCtD
Famotidine—Syncope—Rivastigmine—Alzheimer's disease	0.000627	0.00219	CcSEcCtD
Famotidine—Cough—Memantine—Alzheimer's disease	0.000623	0.00218	CcSEcCtD
Famotidine—Convulsion—Memantine—Alzheimer's disease	0.000619	0.00216	CcSEcCtD
Famotidine—Palpitations—Rivastigmine—Alzheimer's disease	0.000618	0.00216	CcSEcCtD
Famotidine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000614	0.00215	CcSEcCtD
Famotidine—Anorexia—Donepezil—Alzheimer's disease	0.000612	0.00214	CcSEcCtD
Famotidine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00061	0.00213	CcSEcCtD
Famotidine—Cough—Rivastigmine—Alzheimer's disease	0.00061	0.00213	CcSEcCtD
Famotidine—Chest pain—Memantine—Alzheimer's disease	0.000608	0.00213	CcSEcCtD
Famotidine—Myalgia—Memantine—Alzheimer's disease	0.000608	0.00213	CcSEcCtD
Famotidine—Arthralgia—Memantine—Alzheimer's disease	0.000608	0.00213	CcSEcCtD
Famotidine—Anxiety—Memantine—Alzheimer's disease	0.000606	0.00212	CcSEcCtD
Famotidine—Convulsion—Rivastigmine—Alzheimer's disease	0.000605	0.00212	CcSEcCtD
Famotidine—Chest pain—Rivastigmine—Alzheimer's disease	0.000595	0.00208	CcSEcCtD
Famotidine—Myalgia—Rivastigmine—Alzheimer's disease	0.000595	0.00208	CcSEcCtD
Famotidine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000595	0.00208	CcSEcCtD
Famotidine—Dry mouth—Memantine—Alzheimer's disease	0.000595	0.00208	CcSEcCtD
Famotidine—Asthenia—Galantamine—Alzheimer's disease	0.000594	0.00208	CcSEcCtD
Famotidine—Anxiety—Rivastigmine—Alzheimer's disease	0.000593	0.00207	CcSEcCtD
Famotidine—Confusional state—Memantine—Alzheimer's disease	0.000588	0.00206	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000585	0.00205	CcSEcCtD
Famotidine—Oedema—Memantine—Alzheimer's disease	0.000583	0.00204	CcSEcCtD
Famotidine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000582	0.00203	CcSEcCtD
Famotidine—Insomnia—Donepezil—Alzheimer's disease	0.000581	0.00203	CcSEcCtD
Famotidine—Infection—Memantine—Alzheimer's disease	0.000579	0.00203	CcSEcCtD
Famotidine—Paraesthesia—Donepezil—Alzheimer's disease	0.000577	0.00202	CcSEcCtD
Famotidine—Confusional state—Rivastigmine—Alzheimer's disease	0.000575	0.00201	CcSEcCtD
Famotidine—Shock—Memantine—Alzheimer's disease	0.000574	0.00201	CcSEcCtD
Famotidine—Somnolence—Donepezil—Alzheimer's disease	0.000571	0.002	CcSEcCtD
Famotidine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000571	0.002	CcSEcCtD
Famotidine—Oedema—Rivastigmine—Alzheimer's disease	0.00057	0.00199	CcSEcCtD
Famotidine—Diarrhoea—Galantamine—Alzheimer's disease	0.000567	0.00198	CcSEcCtD
Famotidine—Infection—Rivastigmine—Alzheimer's disease	0.000567	0.00198	CcSEcCtD
Famotidine—Dyspepsia—Donepezil—Alzheimer's disease	0.000565	0.00198	CcSEcCtD
Famotidine—Shock—Rivastigmine—Alzheimer's disease	0.000561	0.00196	CcSEcCtD
Famotidine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000558	0.00195	CcSEcCtD
Famotidine—Decreased appetite—Donepezil—Alzheimer's disease	0.000558	0.00195	CcSEcCtD
Famotidine—Anorexia—Memantine—Alzheimer's disease	0.000556	0.00194	CcSEcCtD
Famotidine—Fatigue—Donepezil—Alzheimer's disease	0.000554	0.00194	CcSEcCtD
Famotidine—Constipation—Donepezil—Alzheimer's disease	0.000549	0.00192	CcSEcCtD
Famotidine—Pain—Donepezil—Alzheimer's disease	0.000549	0.00192	CcSEcCtD
Famotidine—Dizziness—Galantamine—Alzheimer's disease	0.000548	0.00192	CcSEcCtD
Famotidine—Anorexia—Rivastigmine—Alzheimer's disease	0.000544	0.0019	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000531	0.00186	CcSEcCtD
Famotidine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000529	0.00185	CcSEcCtD
Famotidine—Insomnia—Memantine—Alzheimer's disease	0.000527	0.00184	CcSEcCtD
Famotidine—Vomiting—Galantamine—Alzheimer's disease	0.000527	0.00184	CcSEcCtD
Famotidine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000525	0.00184	CcSEcCtD
Famotidine—Paraesthesia—Memantine—Alzheimer's disease	0.000523	0.00183	CcSEcCtD
Famotidine—Rash—Galantamine—Alzheimer's disease	0.000522	0.00183	CcSEcCtD
Famotidine—Dermatitis—Galantamine—Alzheimer's disease	0.000522	0.00183	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00052	0.00182	CcSEcCtD
Famotidine—Headache—Galantamine—Alzheimer's disease	0.000519	0.00182	CcSEcCtD
Famotidine—Somnolence—Memantine—Alzheimer's disease	0.000518	0.00181	CcSEcCtD
Famotidine—Insomnia—Rivastigmine—Alzheimer's disease	0.000516	0.0018	CcSEcCtD
Famotidine—Dyspepsia—Memantine—Alzheimer's disease	0.000513	0.00179	CcSEcCtD
Famotidine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000512	0.00179	CcSEcCtD
Famotidine—Urticaria—Donepezil—Alzheimer's disease	0.00051	0.00178	CcSEcCtD
Famotidine—Abdominal pain—Donepezil—Alzheimer's disease	0.000508	0.00177	CcSEcCtD
Famotidine—Body temperature increased—Donepezil—Alzheimer's disease	0.000508	0.00177	CcSEcCtD
Famotidine—Somnolence—Rivastigmine—Alzheimer's disease	0.000507	0.00177	CcSEcCtD
Famotidine—Decreased appetite—Memantine—Alzheimer's disease	0.000507	0.00177	CcSEcCtD
Famotidine—Fatigue—Memantine—Alzheimer's disease	0.000503	0.00176	CcSEcCtD
Famotidine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000502	0.00176	CcSEcCtD
Famotidine—Pain—Memantine—Alzheimer's disease	0.000499	0.00174	CcSEcCtD
Famotidine—Constipation—Memantine—Alzheimer's disease	0.000499	0.00174	CcSEcCtD
Famotidine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000496	0.00173	CcSEcCtD
Famotidine—Nausea—Galantamine—Alzheimer's disease	0.000492	0.00172	CcSEcCtD
Famotidine—Fatigue—Rivastigmine—Alzheimer's disease	0.000492	0.00172	CcSEcCtD
Famotidine—Pain—Rivastigmine—Alzheimer's disease	0.000488	0.00171	CcSEcCtD
Famotidine—Constipation—Rivastigmine—Alzheimer's disease	0.000488	0.00171	CcSEcCtD
Famotidine—Feeling abnormal—Memantine—Alzheimer's disease	0.00048	0.00168	CcSEcCtD
Famotidine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000477	0.00167	CcSEcCtD
Famotidine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000473	0.00165	CcSEcCtD
Famotidine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00047	0.00164	CcSEcCtD
Famotidine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000466	0.00163	CcSEcCtD
Famotidine—Urticaria—Memantine—Alzheimer's disease	0.000463	0.00162	CcSEcCtD
Famotidine—Abdominal pain—Memantine—Alzheimer's disease	0.000461	0.00161	CcSEcCtD
Famotidine—Body temperature increased—Memantine—Alzheimer's disease	0.000461	0.00161	CcSEcCtD
Famotidine—Asthenia—Donepezil—Alzheimer's disease	0.000461	0.00161	CcSEcCtD
Famotidine—Pruritus—Donepezil—Alzheimer's disease	0.000454	0.00159	CcSEcCtD
Famotidine—Urticaria—Rivastigmine—Alzheimer's disease	0.000453	0.00158	CcSEcCtD
Famotidine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000451	0.00158	CcSEcCtD
Famotidine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000451	0.00158	CcSEcCtD
Famotidine—Diarrhoea—Donepezil—Alzheimer's disease	0.000439	0.00154	CcSEcCtD
Famotidine—Hypersensitivity—Memantine—Alzheimer's disease	0.00043	0.0015	CcSEcCtD
Famotidine—Dizziness—Donepezil—Alzheimer's disease	0.000425	0.00148	CcSEcCtD
Famotidine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00042	0.00147	CcSEcCtD
Famotidine—Asthenia—Memantine—Alzheimer's disease	0.000418	0.00146	CcSEcCtD
Famotidine—Pruritus—Memantine—Alzheimer's disease	0.000412	0.00144	CcSEcCtD
Famotidine—Asthenia—Rivastigmine—Alzheimer's disease	0.000409	0.00143	CcSEcCtD
Famotidine—Vomiting—Donepezil—Alzheimer's disease	0.000408	0.00143	CcSEcCtD
Famotidine—Rash—Donepezil—Alzheimer's disease	0.000405	0.00142	CcSEcCtD
Famotidine—Dermatitis—Donepezil—Alzheimer's disease	0.000404	0.00141	CcSEcCtD
Famotidine—Pruritus—Rivastigmine—Alzheimer's disease	0.000403	0.00141	CcSEcCtD
Famotidine—Headache—Donepezil—Alzheimer's disease	0.000402	0.00141	CcSEcCtD
Famotidine—Diarrhoea—Memantine—Alzheimer's disease	0.000399	0.00139	CcSEcCtD
Famotidine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00039	0.00136	CcSEcCtD
Famotidine—Dizziness—Memantine—Alzheimer's disease	0.000386	0.00135	CcSEcCtD
Famotidine—Nausea—Donepezil—Alzheimer's disease	0.000381	0.00133	CcSEcCtD
Famotidine—Dizziness—Rivastigmine—Alzheimer's disease	0.000377	0.00132	CcSEcCtD
Famotidine—Vomiting—Memantine—Alzheimer's disease	0.000371	0.0013	CcSEcCtD
Famotidine—Rash—Memantine—Alzheimer's disease	0.000368	0.00129	CcSEcCtD
Famotidine—Dermatitis—Memantine—Alzheimer's disease	0.000367	0.00128	CcSEcCtD
Famotidine—Headache—Memantine—Alzheimer's disease	0.000365	0.00128	CcSEcCtD
Famotidine—Vomiting—Rivastigmine—Alzheimer's disease	0.000363	0.00127	CcSEcCtD
Famotidine—Rash—Rivastigmine—Alzheimer's disease	0.00036	0.00126	CcSEcCtD
Famotidine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000359	0.00126	CcSEcCtD
Famotidine—Headache—Rivastigmine—Alzheimer's disease	0.000357	0.00125	CcSEcCtD
Famotidine—Nausea—Memantine—Alzheimer's disease	0.000346	0.00121	CcSEcCtD
Famotidine—Nausea—Rivastigmine—Alzheimer's disease	0.000339	0.00118	CcSEcCtD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000199	0.004	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000198	0.00397	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP46A1—Alzheimer's disease	0.000195	0.00391	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000192	0.00385	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000192	0.00385	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000192	0.00385	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00019	0.00382	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000189	0.00381	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000188	0.00379	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GAL—Alzheimer's disease	0.000183	0.00367	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000183	0.00367	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000177	0.00356	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIK1—Alzheimer's disease	0.000173	0.00347	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHRNA7—Alzheimer's disease	0.000173	0.00347	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000172	0.00346	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000171	0.00343	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000166	0.00333	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000164	0.0033	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000162	0.00326	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000162	0.00325	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000161	0.00324	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00016	0.00322	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PYY—Alzheimer's disease	0.000149	0.00299	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000149	0.00299	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000147	0.00295	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHAT—Alzheimer's disease	0.000147	0.00295	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIK2—Alzheimer's disease	0.000147	0.00295	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—NPY—Alzheimer's disease	0.000143	0.00288	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—IAPP—Alzheimer's disease	0.000143	0.00287	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000139	0.00278	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CRH—Alzheimer's disease	0.000138	0.00278	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PYY—Alzheimer's disease	0.000135	0.00272	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000132	0.00265	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—NPS—Alzheimer's disease	0.000131	0.00264	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIA1—Alzheimer's disease	0.000131	0.00263	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000129	0.0026	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000128	0.00257	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000126	0.00254	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—SST—Alzheimer's disease	0.000125	0.00252	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000124	0.0025	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHRNB2—Alzheimer's disease	0.000124	0.00249	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000124	0.00248	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000124	0.00248	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000122	0.00245	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—APP—Alzheimer's disease	0.000122	0.00245	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000121	0.00243	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CDK5—Alzheimer's disease	0.000117	0.00236	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOB—Alzheimer's disease	0.000116	0.00233	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—ACHE—Alzheimer's disease	0.000114	0.00229	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR6—Alzheimer's disease	0.000113	0.00227	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHRNA4—Alzheimer's disease	0.000113	0.00226	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000112	0.00225	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000112	0.00225	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000106	0.00213	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000104	0.00208	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000103	0.00207	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000101	0.00203	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BCHE—Alzheimer's disease	9.92e-05	0.00199	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—DLG4—Alzheimer's disease	9.68e-05	0.00195	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIN2B—Alzheimer's disease	9.47e-05	0.0019	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GAL—Alzheimer's disease	9.37e-05	0.00188	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PLCB1—Alzheimer's disease	9.36e-05	0.00188	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TTR—Alzheimer's disease	9.14e-05	0.00184	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	9.09e-05	0.00183	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	9.06e-05	0.00182	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	9.04e-05	0.00182	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DHCR24—Alzheimer's disease	8.91e-05	0.00179	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	8.8e-05	0.00177	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	8.63e-05	0.00173	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.6e-05	0.00173	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.51e-05	0.00171	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—NPY—Alzheimer's disease	8.11e-05	0.00163	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	8.1e-05	0.00163	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	8.09e-05	0.00163	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCR5—Alzheimer's disease	8.07e-05	0.00162	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IAPP—Alzheimer's disease	8.06e-05	0.00162	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PYY—Alzheimer's disease	7.99e-05	0.00161	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2A—Alzheimer's disease	7.9e-05	0.00159	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CRH—Alzheimer's disease	7.82e-05	0.00157	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	7.82e-05	0.00157	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA4—Alzheimer's disease	7.57e-05	0.00152	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	7.47e-05	0.0015	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—NPS—Alzheimer's disease	7.42e-05	0.00149	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—NPY—Alzheimer's disease	7.36e-05	0.00148	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IAPP—Alzheimer's disease	7.32e-05	0.00147	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GAPDHS—Alzheimer's disease	7.12e-05	0.00143	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CRH—Alzheimer's disease	7.1e-05	0.00143	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—SST—Alzheimer's disease	7.08e-05	0.00142	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GAB2—Alzheimer's disease	7.08e-05	0.00142	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.04e-05	0.00141	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDK5—Alzheimer's disease	6.93e-05	0.00139	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PRKCG—Alzheimer's disease	6.92e-05	0.00139	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—F2—Alzheimer's disease	6.92e-05	0.00139	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—APP—Alzheimer's disease	6.9e-05	0.00139	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ATP5A1—Alzheimer's disease	6.75e-05	0.00136	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—NPS—Alzheimer's disease	6.74e-05	0.00135	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PPP3CA—Alzheimer's disease	6.7e-05	0.00135	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	6.69e-05	0.00134	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR6—Alzheimer's disease	6.67e-05	0.00134	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PLCB1—Alzheimer's disease	6.51e-05	0.00131	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLD3—Alzheimer's disease	6.44e-05	0.00129	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GAB2—Alzheimer's disease	6.43e-05	0.00129	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—SST—Alzheimer's disease	6.43e-05	0.00129	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—APP—Alzheimer's disease	6.26e-05	0.00126	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD17B10—Alzheimer's disease	6.17e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCL2—Alzheimer's disease	6.17e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSENEN—Alzheimer's disease	6.06e-05	0.00122	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.02e-05	0.00121	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CALM1—Alzheimer's disease	5.99e-05	0.0012	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.99e-05	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APH1A—Alzheimer's disease	5.97e-05	0.0012	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP46A1—Alzheimer's disease	5.94e-05	0.00119	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PLCB1—Alzheimer's disease	5.91e-05	0.00119	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NCSTN—Alzheimer's disease	5.81e-05	0.00117	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ND1—Alzheimer's disease	5.74e-05	0.00115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LRP1—Alzheimer's disease	5.67e-05	0.00114	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GAL—Alzheimer's disease	5.54e-05	0.00111	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GFAP—Alzheimer's disease	5.54e-05	0.00111	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CREB1—Alzheimer's disease	5.13e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	4.99e-05	0.001	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—A2M—Alzheimer's disease	4.88e-05	0.000981	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCG—Alzheimer's disease	4.81e-05	0.000967	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSEN2—Alzheimer's disease	4.73e-05	0.00095	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.65e-05	0.000934	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR5—Alzheimer's disease	4.56e-05	0.000916	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.46e-05	0.000896	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCG—Alzheimer's disease	4.37e-05	0.000878	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NPY—Alzheimer's disease	4.35e-05	0.000874	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IAPP—Alzheimer's disease	4.32e-05	0.000869	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA4—Alzheimer's disease	4.24e-05	0.000852	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CRH—Alzheimer's disease	4.2e-05	0.000843	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.19e-05	0.000841	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.14e-05	0.000832	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR5—Alzheimer's disease	4.14e-05	0.000832	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—Alzheimer's disease	4.05e-05	0.000814	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	3.99e-05	0.000801	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NPS—Alzheimer's disease	3.98e-05	0.000799	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PPP3CA—Alzheimer's disease	3.96e-05	0.000795	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2—Alzheimer's disease	3.91e-05	0.000786	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTK2B—Alzheimer's disease	3.9e-05	0.000784	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GAB2—Alzheimer's disease	3.8e-05	0.000763	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SST—Alzheimer's disease	3.8e-05	0.000763	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK2—Alzheimer's disease	3.8e-05	0.000763	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CALM1—Alzheimer's disease	3.78e-05	0.000759	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	3.78e-05	0.000759	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GSK3A—Alzheimer's disease	3.76e-05	0.000756	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APP—Alzheimer's disease	3.7e-05	0.000743	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TPI1—Alzheimer's disease	3.7e-05	0.000743	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CHAT—Alzheimer's disease	3.7e-05	0.000743	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLD3—Alzheimer's disease	3.6e-05	0.000724	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.6e-05	0.000724	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.56e-05	0.000716	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2—Alzheimer's disease	3.55e-05	0.000714	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOB—Alzheimer's disease	3.55e-05	0.000712	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLCB1—Alzheimer's disease	3.49e-05	0.000701	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	3.46e-05	0.000694	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	3.41e-05	0.000686	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.38e-05	0.000679	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	3.33e-05	0.000668	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—A2M—Alzheimer's disease	3.3e-05	0.000662	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGFR—Alzheimer's disease	3.26e-05	0.000654	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CREB1—Alzheimer's disease	3.24e-05	0.00065	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ND1—Alzheimer's disease	3.21e-05	0.000645	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADAM10—Alzheimer's disease	3.18e-05	0.000639	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—Alzheimer's disease	3.17e-05	0.000636	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.14e-05	0.000631	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—S100B—Alzheimer's disease	3.01e-05	0.000604	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.87e-05	0.000577	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ACHE—Alzheimer's disease	2.87e-05	0.000576	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—Alzheimer's disease	2.86e-05	0.000575	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	2.83e-05	0.00057	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1R—Alzheimer's disease	2.77e-05	0.000556	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	2.69e-05	0.00054	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ENO1—Alzheimer's disease	2.69e-05	0.00054	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LPL—Alzheimer's disease	2.65e-05	0.000533	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	2.64e-05	0.00053	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MEF2C—Alzheimer's disease	2.63e-05	0.000529	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCG—Alzheimer's disease	2.58e-05	0.000519	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGF—Alzheimer's disease	2.51e-05	0.000505	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BCHE—Alzheimer's disease	2.5e-05	0.000502	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.48e-05	0.000497	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR5—Alzheimer's disease	2.45e-05	0.000491	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—Alzheimer's disease	2.39e-05	0.000481	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	2.36e-05	0.000474	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	2.29e-05	0.000459	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.25e-05	0.000453	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CALM1—Alzheimer's disease	2.23e-05	0.000449	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—Alzheimer's disease	2.23e-05	0.000447	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—Alzheimer's disease	2.23e-05	0.000447	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-05	0.000443	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-05	0.000427	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2—Alzheimer's disease	2.1e-05	0.000422	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.07e-05	0.000416	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.07e-05	0.000416	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-05	0.000413	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.98e-05	0.000399	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	1.97e-05	0.000396	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	1.96e-05	0.000394	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GSK3B—Alzheimer's disease	1.93e-05	0.000387	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-05	0.000384	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.91e-05	0.000384	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—Alzheimer's disease	1.9e-05	0.000382	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.89e-05	0.00038	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.87e-05	0.000376	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-05	0.000376	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.85e-05	0.000371	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-05	0.000369	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.79e-05	0.00036	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-05	0.000335	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.65e-05	0.000331	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	1.61e-05	0.000324	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.61e-05	0.000323	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.59e-05	0.000319	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CALM1—Alzheimer's disease	1.51e-05	0.000303	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.5e-05	0.000302	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.5e-05	0.000302	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—Alzheimer's disease	1.5e-05	0.000302	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—Alzheimer's disease	1.49e-05	0.000299	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.48e-05	0.000296	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.43e-05	0.000287	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—Alzheimer's disease	1.42e-05	0.000284	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-05	0.000283	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.4e-05	0.000281	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.32e-05	0.000265	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—Alzheimer's disease	1.31e-05	0.000263	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-05	0.000261	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-05	0.000261	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.29e-05	0.00026	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—Alzheimer's disease	1.28e-05	0.000258	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.28e-05	0.000257	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-05	0.000241	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	1.13e-05	0.000226	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.1e-05	0.000221	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-05	0.000221	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.1e-05	0.00022	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	1.03e-05	0.000207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPL—Alzheimer's disease	1e-05	0.000202	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—Alzheimer's disease	9.07e-06	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	9.04e-06	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	8.44e-06	0.00017	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—Alzheimer's disease	8.41e-06	0.000169	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	8.34e-06	0.000167	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—Alzheimer's disease	8.31e-06	0.000167	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	7.66e-06	0.000154	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	7.33e-06	0.000147	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—Alzheimer's disease	7.19e-06	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	6.3e-06	0.000127	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	5.76e-06	0.000116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	5.18e-06	0.000104	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	2.9e-06	5.82e-05	CbGpPWpGaD
